Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medication
Authors
Abstract:
Background: The present study was conducted to determine the prevalence of metabolic syndrome (Mets) in schizophrenic patients in a 6-month period of treatment with antipsychotic medication. Methods: In this study, 60 volunteer schizophrenic patients were included. At the onset and 6 month after treated with antipsychotic medication, fasting blood sugar (FBS), serum triglyceride (TG), high density lipoprotein (HDL), weigh, waist circumference (WC), and blood pressure were determined. We defined Mets according to ATPIII criteria. Results: After 6 month treatment with antipsychotics drugs, the mean WC, serum TG, HDL, systolic and diastolic blood pressure increased but the changes of WC and HDL were statistically significant (P<0.05). We found that percentage of patients with high WC, low HDL levels, and Mets increased after treatment which was statistically significant (P<0.05). Conclusion: It is recommended that nutritional and life style changes intervention should be implanted for schizophrenic patients undergoing treatment.
similar resources
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
UNLABELLED The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and diabetes. There are limited data on the prevalence of the metabolic syndrome in European patients suffering from schizophrenia. METHODS All consecutive patients with schizophrenia at our university psychiatric hospital and affiliate services were entered in an extensive prospective met...
full textPrevalence of Metabolic Syndrome in Patients with Periodontal Disease
Background & Aims: Metabolic syndrome is composed of interrelated cardiovascular and cardiometabolic risk factors. Moreover, recent researches have illustrated the association of systemic diseases and periodontitis. Thus, the early diagnosis of this syndrome, as a cardiometabolic risk factor, seems necessary. The aim of this study was to evaluate the prevalence of metabolic syndrome in patients...
full textPrevalence of metabolic syndrome among patients with schizophrenia in Singapore.
INTRODUCTION Schizophrenia has been associated with an increased risk of cardiometabolic morbidity and mortality. Metabolic syndrome (MetS), a reliable predictor of cardiovascular-related morbidity and mortality, has also been shown to be more prevalent in patients with schizophrenia. In this study, we investigated the prevalence of MetS in a sample of patients with schizophrenia in Singapore, ...
full textPrevalence of metabolic syndrome among patients with Schizophrenia in Palestine
BACKGROUND Metabolic syndrome (MS) is a cluster of the most dangerous cardiac risk factors and is associated with high mortality. Ethnic differences in metabolic syndrome (MS) criteria and prevalence rates have been reported. The purpose of this study was to investigate the MS prevalence among patients with schizophrenia in Palestine. METHODS We recruited 250 patients with schizophrenia from ...
full textTreatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication
BACKGROUND AND AIM Some of the most significant problems encountered in the treatment of schizophrenia are non-adherence to the treatment with oral neuroleptics and difficult recovery of social functioning, after its impairment by negative psychotic symptoms and the progression of the disease with episodes of remission and relapse. METHODS This study comparatively assesses the parameters "soc...
full textMetabolic Disturbances with Antipsychotic Medication
! Increasing clinical experience with atypical antipsychotics has demonstrated an association between these medications and metabolic disturbances, including hyperglycaemia, diabetes mellitus, weight gain and dyslipidaemia. ! The term metabolic syndrome describes the incidence of a number of interrelated metabolic disturbances occurring in one patient and is becoming increasingly recognised as ...
full textMy Resources
Journal title
volume 11 issue 3
pages 11- 0
publication date 2020-05
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023